Related Experiment Video
Updated: Aug 24, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP
Jae-Hoon Song1, Sook-In Jung, Kwan Soo Ko
1Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Asian-Pacific Research Foundation for Infectious Diseases, 50 Il-won dong, Kangnam-ku, Seoul 135-710, Korea. jhsong@smc.samsung.co.kr
Abstract:
A total of 685 clinical Streptococcus pneumoniae isolates from patients with pneumococcal diseases were collected from 14 centers in 11 Asian countries from January 2000 to June 2001. The in vitro susceptibilities of the isolates to 14 antimicrobial agents were determined by the broth microdilution test. Among the isolates tested, 483 (52.4%) were not susceptible to penicillin, 23% were intermediate, and 29.4% were penicillin resistant (MICs >/= 2 mg/liter). Isolates from Vietnam showed the highest prevalence of penicillin resistance (71.4%), followed by those from Korea (54.8%), Hong Kong (43.2%), and Taiwan (38.6%). The penicillin MICs at which 90% of isolates are inhibited (MIC(90)s) were 4 mg/liter among isolates from Vietnam, Hong Kong, Korea, and Taiwan. The prevalence of erythromycin resistance was also very high in Vietnam (92.1%), Taiwan (86%), Korea (80.6%), Hong Kong (76.8%), and China (73.9%). The MIC(90)s of erythromycin were >32 mg/liter among isolates from Korea, Vietnam, China, Taiwan, Singapore, Malaysia, and Hong Kong. Isolates from Hong Kong showed the highest rate of ciprofloxacin resistance (11.8%), followed by isolates from Sri Lanka (9.5%), the Philippines (9.1%), and Korea (6.5%). Multilocus sequence typing showed that the spread of the Taiwan(19F) clone and the Spain(23F) clone could be one of the major reasons for the rapid increases in antimicrobial resistance among S. pneumoniae isolates in Asia. Data from the multinational surveillance study clearly documented distinctive increases in the prevalence rates and the levels of antimicrobial resistance among S. pneumoniae isolates in many Asian countries, which are among the highest in the world published to date.
Insights
Antimicrobial resistance in Streptococcus pneumoniae is alarmingly high across Asia. Penicillin resistance exceeded 50% in many countries, with specific clones contributing to this rise.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Streptococcus pneumoniae causes severe pneumococcal diseases globally.
- Antimicrobial resistance (AMR) poses a significant threat to effective treatment.
- Surveillance of AMR in Asia is crucial due to high population density and varying healthcare access.
Purpose of the Study:
- To assess the in vitro antimicrobial susceptibility of clinical Streptococcus pneumoniae isolates across multiple Asian countries.
- To identify trends and prevalence of resistance to key antimicrobial agents.
- To investigate potential drivers of increasing antimicrobial resistance.
Main Methods:
- Collection of 685 clinical S. pneumoniae isolates from 14 centers in 11 Asian countries (2000-2001).
- Determination of in vitro susceptibilities to 14 antimicrobial agents using broth microdilution.
- Antimicrobial resistance (AMR) profiling and Minimum Inhibitory Concentration (MIC) determination.
- Multilocus sequence typing (MLST) to identify prevalent clones.
Main Results:
- Over 52% of isolates were not susceptible to penicillin; 29.4% were resistant (MICs ≥ 2 mg/liter).
- High rates of erythromycin resistance were observed, particularly in Vietnam (92.1%) and Taiwan (86%).
- Specific clones, Taiwan(19F) and Spain(23F), were identified as potential drivers of increasing AMR.
Conclusions:
- Significant increases in antimicrobial resistance prevalence and levels were documented among S. pneumoniae isolates in many Asian countries.
- Resistance rates in this study are among the highest reported globally.
- Urgent public health strategies are needed to combat the escalating antimicrobial resistance crisis in the region.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Pneumonia I: Introduction
Development of Antibiotic Resistance
Staphylococcal Skin Infections